The vaginal mucosa is a common site for local and systemic delivery of medication. This study aims to compare the safety and toxicological profile of RheoSpray, a proprietary sprayable topical gel compounding base, to the profile of the positive control Gynoll II, using a 3D model of the human vaginal mucosa. Results have demonstrated that RheoSpray presented an ET50 superior to 24 hr, as oppos...